Kerry Wentworth, Chief Regulatory Officer: Nuvation Bio NUVB Planned sale · Filed 04/17

Trade details

Type: Planned sale notice
Stock: Nuvation Bio NUVB
Person: Kerry WentworthChief Regulatory Officer
Planned sale date: 26/04/17
Filed: 26/04/17

More to sell after $903.5K in 3 months

Nuvation Bio trades, last 26 weeks

What else happened in Nuvation Bio around then

Filed or reported within 30 days of the trade day · 03/18~05/17

Kerry Wentworth's recent trades

Kerry WentworthChief Regulatory Officer
Sell10b5-1 planNuvation Bio
Sell10b5-1 plan
Nuvation Bio
NUVB
$379.3K
63,000 sh
$379.3K
Filed 06/24
Traded 06/23
Kerry WentworthChief Regulatory Officer
Planned sale10b5-1 planNuvation Bio
Planned sale10b5-1 plan
Nuvation Bio
NUVB
$362.9K
63,000 sh
$362.9K
Filed 06/23
Traded 06/23
Kerry WentworthChief Regulatory Officer
Sell10b5-1 planNuvation Bio
Sell10b5-1 plan
Nuvation Bio
NUVB
$184.1K
36,750 sh
$184.1K
Filed 04/21
Traded 04/17
Kerry WentworthChief Regulatory Officer
Sell10b5-1 planNuvation Bio
Sell10b5-1 plan
Nuvation Bio
NUVB
$904K
200,000 sh
$904K
Filed 04/08
Traded 04/06
Kerry WentworthChief Regulatory Officer
Planned sale10b5-1 planNuvation Bio
Planned sale10b5-1 plan
Nuvation Bio
NUVB
$882K
200,000 sh
$882K
Filed 04/06
Traded 04/06